I agree that this site is using cookies. You can find further informations here.
X
Aljumaily, Raid
42  results:
Search for persons X
?
1

Analysis of Radiation Therapy Quality Assurance in NRG Onco..:

Tchelebi, Leila T. ; Winter, Kathryn A. ; Abrams, Ross A....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  1 - p. 107-114 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comparing the rate of immunotherapy treatment change due to..:

Chua, Kevin J. ; Kronstedt, Shane ; Kaldany, Alain...
Cancer Reports.  7 (2024)  2 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
3

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients..:

Patel, Manish R. ; Johnson, Melissa ; Winer, Ira...
Cancer Immunology, Immunotherapy.  73 (2024)  5 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topote..:

Johnson, Melissa L ; Patel, Manish R ; Aljumaily, Raid...
The Oncologist.  28 (2023)  7 - p. 640-e559 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Prognostic impact of natural killer cell recovery on minima..:

Keruakous, Amany R. ; Asch, Adam ; Aljumaily, Raid..
Transplant Immunology.  71 (2022)  - p. 101544 , 2022
Link: https://doi.org/10.1016/..
 
?
6

A Phase 1b Trial of Prexasertib in Combination with Standar..:

Moore, Kathleen N. ; Hong, David S. ; Patel, Manish R....
Targeted Oncology.  16 (2021)  5 - p. 569-589 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Pegilodecakin as monotherapy or in combination with anti‐PD..:

Tannir, Nizar M. ; Papadopoulos, Kyriakos P. ; Wong, Deborah J....
International Journal of Cancer.  149 (2021)  2 - p. 403-408 , 2021
Link: https://doi.org/10.1002/..
 
?
8

Tolerability and antitumor activity of cemiplimab, a human ..:

Moreno, Victor ; Garrido, Pilar ; Papadopoulos, Kyriakos P....
Lung Cancer.  155 (2021)  - p. 151-155 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Trilaciclib dose selection: an integrated pharmacokinetic a..:

Li, Chao ; Hart, Lowell ; Owonikoko, Taofeek K....
Cancer Chemotherapy and Pharmacology.  87 (2021)  5 - p. 689-700 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Immunologic and tumor responses of pegilodecakin with 5-FU/..:

Hecht, J. Randolph ; Papadopoulos, Kyriakos P. ; Falchook, Gerald S....
Investigational New Drugs.  39 (2020)  1 - p. 182-192 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Avelumab as second-line therapy for metastatic, platinum-tr..:

Apolo, Andrea B ; Ellerton, John A ; Infante, Jeffrey R...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001246 , 2020
Link: https://doi.org/10.1136/..
 
?
12

Myelopreservation with Trilaciclib in Patients Receiving To..:

Hart, Lowell L. ; Ferrarotto, Renata ; Andric, Zoran G....
Advances in Therapy.  38 (2020)  1 - p. 350-365 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Do proton pump inhibitors modulate the efficacy of anti-PD-..:

Mukherjee, Sarbajit ; Ibrahimi, Sami ; Khalid, Bilal...
Journal of Oncology Pharmacy Practice.  25 (2018)  3 - p. 762-764 , 2018
Link: https://doi.org/10.1177/..
 
?
14

Cemiplimab (REGN2810), a Fully Human Anti-PD-1 Monoclonal A..:

Papadopoulos, Kyriakos P ; Owonikoko, Taofeek K ; Johnson, Melissa L...
SKIN The Journal of Cutaneous Medicine.  2 (2018)  - p. S45 , 2018
Link: https://doi.org/10.25251..
 
?
15

A first-in-human phase 1a study of the bispecific anti-DLL4..:

Jimeno, Antonio ; Moore, Kathleen N. ; Gordon, Michael...
Investigational New Drugs.  37 (2018)  3 - p. 461-472 , 2018
Link: https://doi.org/10.1007/..
 
1-15